Egbuonu-Davis Lisa sold $6K of PHR
Egbuonu-Davis Lisa sold 536 shares of Phreesia, Inc. (PHR) at $10.70 on 2026-07-14 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed open-market sale reduces insider holdings but, because it is under a pre-arranged 10b5-1 plan, it is generally less informative than discretionary selling.
Market read
Traders may log the transaction for sentiment tracking, but there is no new fundamental information to drive a decisive trade.
What to watch
The article does not state whether other insiders sold/bought around the same period, nor does it provide context on total planned sales or remaining 10b5-1 volume.
Background
The article is a SEC Form 4 disclosure for an insider transaction at Phreesia, Inc.
Ticker impact
Phreesia director Egbuonu-Davis Lisa sold 536 shares in an open-market transaction at $10.70 on 2026-07-14 under a 10b5-1 plan.
Low likelihood of a sustained price move; any near-term reaction would likely be muted.
The filing is a Form 4 insider transaction, but the article provides no new operational, financial, or regulatory catalyst beyond the sale details and confirms a pre-arranged 10b5-1 plan.
Market effects
No clear sector read-through from a single director 10b5-1 sale.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can coincide with internal liquidity needs or risk management, which some traders may still treat as a mild negative sentiment input.
Key entities
- issuerPhreesia, Inc.
Company whose director insider sale is disclosed on Form 4.
- insiderEgbuonu-Davis Lisa
Director who sold 536 shares at $10.70 under a 10b5-1 plan.
